|
RNPC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.134430E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.496200E-01 |
| Normal-vs-Stage2 |
3.334400E-02 |
| Normal-vs-Stage3 |
1.750080E-02 |
| Normal-vs-Stage4 |
3.008200E-01 |
| Stage1-vs-Stage2 |
1.065220E-01 |
| Stage1-vs-Stage3 |
4.425900E-02 |
| Stage1-vs-Stage4 |
6.824200E-01 |
| Stage2-vs-Stage3 |
8.872000E-01 |
| Stage2-vs-Stage4 |
3.382200E-01 |
| Stage3-vs-Stage4 |
3.107000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.672240E-01 |
| Normal-vs-AfricanAmerican |
6.247800E-01 |
| Normal-vs-Asian |
5.207800E-01 |
| Caucasian-vs-AfricanAmerican |
6.752600E-01 |
| Caucasian-vs-Asian |
3.796200E-02 |
| AfricanAmerican-vs-Asian |
3.413800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.819000E-01 |
| Normal-vs-Female |
7.000500E-02 |
| Male-vs-Female |
3.655400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.282200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.144220E-01 |
| Normal-vs-Age(61-80Yrs) |
8.564100E-02 |
| Normal-vs-Age(81-100Yrs) |
5.74309999999967E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.855400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.641360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.181970E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.624200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.980000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.380300E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.997200E-03 |
| Classical-VS-Follicular |
2.144400E-02 |
| Classical-VS-Other |
8.353000E-01 |
| Classical-VS-Normal |
4.203800E-01 |
| Tall-VS-Follicular |
6.865200E-01 |
| Tall-VS-Other |
5.268600E-01 |
| Tall-VS-Normal |
6.636600E-03 |
| Follicular-VS-Other |
5.937400E-01 |
| Follicular-VS-Normal |
2.390300E-02 |
| Other-VS-Normal |
6.049400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.732000E-02 |
| Normal-vs-N1 |
4.759000E-01 |
| N0-vs-N1 |
3.696000E-02 |
|
|
